SAB Biotherapeutics, Inc. (SABS)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 4.0500 |
| Open | 4.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 4.0000 - 4.0000 |
| 52-week range | 4.0000 - 10.5000 |
| Volume | |
| Avg. volume | 13,277 |
| Market cap | 37.179M |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
SAB Biotherapeutics ( NASDAQ:SABS ) Full Year 2023 Results Key Financial Results Net loss: US$42.2m (loss widened by...
- Simply Wall St.
Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week
Key Insights SAB Biotherapeutics' significant individual investors ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.